目的：探讨去甲氧柔红霉素（IDA）与预激方案（CAG）联合治疗首发性老年急性髓细胞白血病（AML）的临床效果。方法收集该院2008年6月到2012年1月收治的AML患者80例，按照随机数字表法分为观察组和对照组，每组40例，均给予相应的支持治疗，观察组给予IDA与CAG方案联合治疗，对照组给予柔红霉素（ DA）方案治疗，观察两组治疗效果、生存时间及不良反应。结果观察组治疗有效率为92．5％，控制率为97．5％，高于对照组的67．5％，82．5％（P＜0．05）。观察组平均生存时间高于对照组（P＜0．05），观察组1、2、3年生存率分别为84．6％、58．9％、41．8％，明显高于对照组的61．0％、36．8％、26．4％（均P＜0．05）。两组血红蛋白减少、血小板减少、恶性、呕吐、肾功能异常、骨髓抑制时间具有统计学差异（P＜0．05），肺部感染、直肠、膀胱炎、肝功能损害无统计学差异（P＞0．05）。结论 IDA与CAG联合治疗首发性老年AML效果显著，毒副反应少，具有一定安全性。
直肠癌术后、放化疗后局部复发患者主要采用放射治疗、化疗以及中医中药等多学科、多层次、多方位的综合治疗.患者大多经过多程治疗后复发,体质较差,甚至有明显的恶病质,对这类患者进行大剂量放、化疗或对产生耐药的患者再次进行放疗或者化疗,只能使虚弱的生命更加垂危,加速患者死亡,中医药治疗在此阶段优势凸显出来.中医药外用治疗以扶正祛邪为法则,攻补兼施,达到改善生活质量的作用,所以在直肠癌术后放化疗后局部复发的治疗方法中,中医药外用治疗值得进一步研究探索.
Objective To evaluate the pristine effects of glucocorticoid in the treatment of pancytopenia patients,who were difficult to be diagnosed because they had bone marrow hyperplasia,reticulocyte counts no less than 1%,eliminations of leukemia and other diseases which can cause pancytopenia,not enough evidence of immunorelated pancytopenia. Methods 12 cases of such patients were analyzed retrospectively. Results The total counts of peripheral blood leucocyte,neutrophile granulocyte,haematoglobin of these patients were significantly increased after treatment(P 0.05),and the symptoms,such as bleeding and hypodynamia,were relieved. Conclusion It might have good effect that glucocorticoid application in the early stages for the patients who were meeting the above conditions.
